drug

drug, herbal, medicine, patent, pharma, technology

Conduit Pharmaceuticals Receives Additional Patent Approval for Lead Autoimmune Disease Asset

/

Conduit Pharmaceuticals Inc. (NASDAQ: CDT), a biopharmaceutical company focused on developing treatments for autoimmune and inflammatory diseases, announced today that it has received further patent approval for its lead therapeutic asset targeting autoimmune conditions. The newly granted patent strengthens the company’s intellectual property portfolio and provides added protection for its innovative approach to treating autoimmune […]

diabetes, drug, herbal, medicine, patent, pharma, technology, WHO

WHO and Medicines Patent Pool Support Nigerian Innovation in Health Diagnostic

/

In a landmark step towards strengthening healthcare innovation in Africa, the World Health Organization (WHO) and the Medicines Patent Pool (MPP) have announced strategic support for Nigerian-led advancements in health diagnostics. This collaboration is aimed at fostering local innovation, improving access to affordable diagnostic tools, and enhancing the country’s capacity to respond to pressing public

pharma, battle, dispute, drug, infringement, medicine, patent, technology, Uncategorized

Madras High Court ruled in favor of Pfizer’s patent rights

/

In a recent global patent disputes, the Madras High Court has pronounced a ruling concerning the ongoing patent dispute in the United States involving Pfizer’s drug, VYNDAMAX (also known as TAFAMIDIS), which is used to treat a rare heart condition called transthyretin amyloid cardiomyopathy (ATTR-CM). The case is in focus due to the high stakes

linezolid, battle, dispute, drug, medicine, patent, pharma, Uncategorized

“Linezolid” Patent Revoked After Post-Grant Opposition by Symed Labs

/

The Indian Patent Office has revoked Patent No. 281489 (Application No. 201641013830) following a post-grant opposition filed by Symed Labs. The patent was granted on 20 March, 2017 and the post grant opposition was filed on 5 March, 2018. The patentee had also amended its claims during the opposition proceedings and urged that the application

anti-ageing, drug, medicine, patent, pharma, technology, Uncategorized

Pharma consultant Agrawal filed patent for new anti-ageing drug

/

Sanjay Agrawal, a scientific advisor for the US-based Alkomex GBN Pharma Group and an Ahmedabad-based researcher, has filed for a patent for an anti-aging drug formulation aimed at combating aging at the cellular level. The formulation is designed to address the underlying biological processes of aging, potentially offering a groundbreaking approach to age-related issues. The

Scroll to Top